
Does the use of Rebiyug L lead to increased risk of fractures?
Nov 4, 2023
Does the use of Rebiyug L lead to increased risk of fractures?
Multiple studies conducted on adults have reported a potential correlation between the use of Rebiyug L and a heightened risk of fractures related to osteoporosis specifically those occurring in the hip wrist or spine It was observed that individuals who were administered high doses of this medication were found to be at an increased risk of experiencing fractures High dose usage was defined as receiving multiple daily doses over an extended period typically lasting for a year or more These findings emphasize the importance of closely monitoring patients who are undergoing longterm therapy with Rebiyug L as they may be particularly susceptible to osteoporotic fractures in critical areas of the body It is essential for healthcare professionals to carefully consider the potential risks and benefits associated with this medication when prescribing it to patients especially in cases where longterm therapy may be necessary Regular assessment and evaluation of bone health as well as implementing appropriate preventive measures should be an integral part of the treatment plan to minimize the risk of fractures in susceptible individuals
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹189₹210
₹144₹160
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹135₹150